SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-23-026701
Filing Date
2023-02-28
Accepted
2023-02-28 16:06:00
Documents
88
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cldx-20221231x10k.htm   iXBRL 10-K 2255127
2 EXHIBIT 4.3 cldx-20221231xex4d3.htm EX-4.3 13416
3 EXHIBIT 21.1 cldx-20221231xex21d1.htm EX-21.1 6018
4 EXHIBIT 23.1 cldx-20221231xex23d1.htm EX-23.1 4934
5 EXHIBIT 31.1 cldx-20221231xex31d1.htm EX-31.1 12461
6 EXHIBIT 31.2 cldx-20221231xex31d2.htm EX-31.2 12287
7 EXHIBIT 32 cldx-20221231xex32.htm EX-32 10278
13 GRAPHIC cldx-20221231x10k002.jpg GRAPHIC 57851
  Complete submission text file 0001104659-23-026701.txt   8466247

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cldx-20221231.xsd EX-101.SCH 51980
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cldx-20221231_cal.xml EX-101.CAL 67727
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cldx-20221231_def.xml EX-101.DEF 215036
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cldx-20221231_lab.xml EX-101.LAB 533111
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cldx-20221231_pre.xml EX-101.PRE 390826
82 EXTRACTED XBRL INSTANCE DOCUMENT cldx-20221231x10k_htm.xml XML 1307682
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 23685135
SIC: 2835 In Vitro & In Vivo Diagnostic Substances